Acne Digital Highlights Hub
This course will provide you with valuable updates in Acne Vulgaris presented at the 28th Annual Masters of Pediatric Dermatology and the 18th Annual South Beach Symposium:
Category
Format
Credits
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Atopic Dermatitis Digital Highlights Hub
This course will provide you with valuable updates in Atopic Dermatitis (AD) presented at the 28th Masters of Pediatric Dermatology and the 18th Annual South Beach Symposium from high caliber Dermatology physicians below:
Category
Format
Credits
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Complexities in Childhood Skin Conditions: Being at the Forefront of Care
The ever-increasing presence of a variety of dermatologic conditions across the lifespan, including in neonates, children, and adolescents continues to be a major challenge for healthcare providers in the United States.  Current estimates predict that up to 30% of primary care visits in the US in
Category
Format
Credits
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Clinical Brief: Update on Antiplatelet and Antithrombotic Therapy in the Cardiometabolic Patient
Diabetes increases the risk of cardiovascular and thrombotic adverse events in patients with CAD and PAD compared to patients with these conditions and no concomitant diabetes.
Category
  • CMHC
Format
  • Self-study / Enduring
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
Virtual Symposium - Preventing Adverse Cardiovascular and Limb Events in High-Risk Cardiometabolic Patients with Peripheral Artery Disease: Recent Trials and Advances
Patients with diabetes and PAD, particularly those with concomitant polyvascular disease, are at a greater risk for future adverse cardiovascular and limb events.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
Virtual Symposium: The Evolving Landscape of LDL-C Reduction: Novel Therapies and Approaches
Lowering LDL-C effectively and safely is crucial in preventing ASCVD events. Even with the advances in LDL-C-lowering therapy, there is considerable residual risk due to suboptimal adherence, clinical efficacy, or clinical inertia, which increases the chances of serious adverse CV events.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
When COVID-19 Meets Interstitial Lung Disease: Implications for Acute and Long-Term Management
Patient with ILDs, especially those with a progressive fibrosis phenotype, maybe at a greater risk for having worse outcomes with COVID-19, including during and post-COVID-19 infection.
Category
  • CMHC
  • TME
Format
  • Audio
  • Video
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
2020 CMHC Annual On Demand - Evolving Paradigms in Cardiometabolic Care: Disparities & Advancements
The 2020 Annual CMHC On Demand - Evolving Paradigms in Cardiometabolic Care: Disparities & Advancements will translate the latest cutting-edge medical research into practical, clinical strategies for preventing, delaying, diagnosing, treating, and managing the whole spectrum of cardiometabolic disorders. The goal is to provide the medical community with evidence-based interventions that they can apply immediately in clinical practice to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
Virtual Symposium: ABC Access To Care Initiative: Overcoming Disparities and Gaps in the Diagnosis and Treatment of Familial Hypercholesterolemia
Familial hypercholesterolemia (FH) remains underdiagnosed and undertreated, which increases ASCVD risk, morbidity and mortality in HF patients.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
Virtual Symposium: Tackling Diabetic Kidney Disease Progression: Challenges, Advances, and Novel Approaches
Diabetic kidney disease (DKD) is one of the most common complications of diabetes, affecting up to 50% of persons with diabetes, and leading to increased morbidity and mortality.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation

Pages